These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35760803)

  • 1. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
    Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC5A3 is important for cervical cancer cell growth.
    Li L; Shen FR; Cheng Q; Sun J; Li H; Sun HT; Cai X; Chen M; Yang B; Wang L; Xu L
    Int J Biol Sci; 2023; 19(9):2787-2802. PubMed ID: 37324953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
    Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
    Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotonic activation of the myo-inositol transporter SLC5A3 in HEK293 cells probed by cell volumetry, confocal and super-resolution microscopy.
    Andronic J; Shirakashi R; Pickel SU; Westerling KM; Klein T; Holm T; Sauer M; Sukhorukov VL
    PLoS One; 2015; 10(3):e0119990. PubMed ID: 25756525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
    Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis.
    De Paepe B; Merckx C; Jarošová J; Cannizzaro M; De Bleecker JL
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Gαi3 as a promising target for osteosarcoma treatment.
    Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
    Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia.
    Wei Y; Huang YH; Skopelitis DS; Iyer SV; Costa ASH; Yang Z; Kramer M; Adelman ER; Klingbeil O; Demerdash OE; Polyanskaya SA; Chang K; Goodwin S; Hodges E; McCombie WR; Figueroa ME; Vakoc CR
    Cancer Discov; 2022 Feb; 12(2):450-467. PubMed ID: 34531253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated origin recognition complex subunit 6 expression promotes non-small cell lung cancer cell growth.
    Sang YH; Luo CY; Huang BT; Wu S; Shu J; Lan CG; Zhang F
    Cell Death Dis; 2024 Sep; 15(9):700. PubMed ID: 39349930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBO1 induces histone acetylation and is important for non-small cell lung cancer cell growth.
    Chen TF; Hao HF; Zhang Y; Chen XY; Zhao HS; Yang R; Li P; Qiu LX; Sang YH; Xu C; Liu SX
    Int J Biol Sci; 2022; 18(8):3313-3323. PubMed ID: 35637972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth.
    Zhou T; Sang YH; Cai S; Xu C; Shi MH
    Cell Death Dis; 2021 Jul; 12(8):751. PubMed ID: 34326320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium.
    Chauvin TR; Griswold MD
    Biol Reprod; 2004 Mar; 70(3):744-51. PubMed ID: 14613899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain.
    Buccafusca R; Venditti CP; Kenyon LC; Johanson RA; Van Bockstaele E; Ren J; Pagliardini S; Minarcik J; Golden JA; Coady MJ; Greer JJ; Berry GT
    Mol Genet Metab; 2008; 95(1-2):81-95. PubMed ID: 18675571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
    Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
    Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.
    Zhang J; Yin DP; Zhang Y; Zhang JN; Yang Y; Zhang ZQ; Zhou L; Lv Y; Huang HW; Cao C
    Int J Biol Sci; 2022; 18(15):5667-5680. PubMed ID: 36263185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.